NEW DELHI: The Centre has banned the manufacture, sale and distribution of all oral formulations of nimesulide above 100 mg in immediate-release form, citing risk to human health and the availability ...

Each year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in 1–2% of patients and is the most severe complication of tuberculosis, arising when ...

A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and ...

On Friday, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Novo Nordisk A/S’ (NYSE: NVO) higher dose of Wegovy (semaglutide ...

In a new study, heart attack survivors who received a high, personalized dose of daily vitamin D had a 52 percent lower risk of a repeat heart attack. The results suggest specific vitamin D dosing, ...

In a pooled analysis, the high-dose inactivated influenza vaccine provided superior protection compared with the standard-dose vaccine against hospitalisations for influenza or pneumonia; it also ...

Despite possessing a solid data package on the potential of high-dose Sprinraza in spinal muscular atrophy (SMA), Biogen will now need to revise its application if it hopes to secure an FDA nod. The ...

Sept 23 (Reuters) - The U.S. Food and Drug Administration has declined to approve a higher-dose version of Biogen's (BIIB.O), opens new tab drug for a rare genetic disorder that causes progressive ...

Novo Nordisk (NVO) is planning to submit regulatory filings to obtain FDA approval for a high-dose version of its blockbuster weight loss therapy Wegovy in the U.S., Bloomberg News reported on Tuesday ...

Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, another effort to counter Eli Lilly & Co. in the booming obesity market.

Novo Nordisk A/S (NYSE:NVO) reportedly said on Tuesday that it intends to seek US regulatory approval for a high-dose version of its weight-loss injection Wegovy (semaglutide), another effort to ...

Education equity advocates say they’ve reached “an important milestone” in addressing pandemic-era learning loss after the Los Angeles Unified School District agreed to provide three years of ...